{
  "ptid_time": "053_S_4813_2013-01-10",
  "img_path": "/data/qiuhui/data/adni/images/053_S_4813/2013-01-10/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 13,504 mm³, 55.0% below the reference mean. With a Z-score of -1.31 (9.6th percentile), this represents mild atrophy; hippocampal volume measures 8,034 mm³, 0.1% above the reference mean. With a Z-score of 0.01 (50.3th percentile), this represents normal volume ; whole brain volume measures 1,003,210 mm³, 11.6% below the reference mean. With a Z-score of -1.64 (5.1th percentile), this represents moderate atrophy; entorhinal cortex volume measures 3,699 mm³, 13.2% below the reference mean. With a Z-score of -0.92 (18.0th percentile), this represents normal volume ; fusiform gyrus volume measures 14,377 mm³, 27.8% below the reference mean. With a Z-score of -2.31 (1.0th percentile), this represents significant atrophy; middle temporal gyrus volume measures 21,905 mm³, 2.3% below the reference mean. With a Z-score of -0.19 (42.6th percentile), this represents normal volume . ",
  "text_data": "Age is 68.1 years. Gender is Male. Education: 16 years. MMSE: 29.0. MoCA: 26.0. Laboratory findings: Monocytes: 0.81 (profound elevated); Hemoglobin: 16.50 (significant elevated); Serum Glucose: 137.00 (profound elevated). APOEε4 alleles: 0.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows moderate whole-brain atrophy and significant fusiform gyrus atrophy, but hippocampal and entorhinal cortex volumes are within normal ranges. Cognitive scores (MMSE 29, MoCA 26) are borderline normal (MoCA slightly below typical cutoff of 26/30 for MCI), but the absence of APOE4 and preserved memory-related structures suggests limited Alzheimer's pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (non-amnestic subtype, given preserved hippocampus but significant fusiform atrophy affecting visual/object processing).  \n\n**Confidence:** **Medium** (cognitive scores are near-threshold, and atrophy patterns are atypical for classic AD but still concerning for neurodegeneration).  \n\n*Note: Follow-up with neuropsychological testing (e.g., visuospatial/executive assessments) and longitudinal monitoring is recommended to clarify progression.*",
  "timestamp": "2025-07-26T08:00:40.766358"
}